Among 56 patients with soft-tissue sarcoma, we found three carrying pathogenic or likely pathogenic variants (5%), all in genes previously linked to this tumor type (TP53: 2 patients; NF1: 1 patient)15–17. This evidence concerns the gene TP53 and neoplasm.